NextCure, Inc. 2US.F Stock
NextCure, Inc. Price Chart
NextCure, Inc. 2US.F Financial and Trading Overview
| NextCure, Inc. stock price | 1.51 EUR |
| Previous Close | 1.48 EUR |
| Open | 1.51 EUR |
| Bid | 1.51 EUR x N/A |
| Ask | 1.55 EUR x N/A |
| Day's Range | 1.51 - 1.51 EUR |
| 52 Week Range | 1.12 - 5.04 EUR |
| Volume | 170 EUR |
| Avg. Volume | 6 EUR |
| Market Cap | 41.89M EUR |
| Beta (5Y Monthly) | 0.055877 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.1 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.57 EUR |
2US.F Valuation Measures
| Enterprise Value | -97427504 EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.54727274 |
| PEG Ratio (5 yr expected) | 0.09 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.2710735 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 1.429 |
Trading Information
NextCure, Inc. Stock Price History
| Beta (5Y Monthly) | 0.055877 |
| 52-Week Change | -62.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.04 EUR |
| 52 Week Low | 1.12 EUR |
| 50-Day Moving Average | 1.48 EUR |
| 200-Day Moving Average | 1.9 EUR |
2US.F Share Statistics
| Avg. Volume (3 month) | 6 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 27.83M |
| Float | 18.53M |
| Short Ratio | N/A |
| % Held by Insiders | 8.75% |
| % Held by Institutions | 50.22% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.11% |
| Return on Equity (ttm) | -38.15% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -54199000 EUR |
| EBITDA | -68183000 EUR |
| Net Income Avi to Common (ttm) | -70227000 EUR |
| Diluted EPS (ttm) | -2.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 145.49M EUR |
| Total Cash Per Share (mrq) | 5.23 EUR |
| Total Debt (mrq) | 7.01M EUR |
| Total Debt/Equity (mrq) | 4.55 EUR |
| Current Ratio (mrq) | 23.766 |
| Book Value Per Share (mrq) | 5.552 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -53218000 EUR |
| Levered Free Cash Flow (ttm) | -30738624 EUR |
Profile of NextCure, Inc.
| Country | Germany |
| State | MD |
| City | Beltsville |
| Address | 9000 Virginia Manor Road |
| ZIP | 20705 |
| Phone | 240 399 4900 |
| Website | https://www.nextcure.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 99 |
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company is developing NC410, an immunomedicine designed to block immune suppression mediated by LAIR-1; NC762, a monoclonal antibody that binds specifically to B7-H4, a protein expressed on multiple tumor types; and NC525, a monoclonal antibody that binds to LAIR-1 to functionally kill AML blast cells and leukemic stem cells while preserving normal blood cells, including hematopoietic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
Q&A For NextCure, Inc. Stock
What is a current 2US.F stock price?
NextCure, Inc. 2US.F stock price today per share is 1.51 EUR.
How to purchase NextCure, Inc. stock?
You can buy 2US.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NextCure, Inc.?
The stock symbol or ticker of NextCure, Inc. is 2US.F.
Which industry does the NextCure, Inc. company belong to?
The NextCure, Inc. industry is Biotechnology.
How many shares does NextCure, Inc. have in circulation?
The max supply of NextCure, Inc. shares is 29.61M.
What is NextCure, Inc. Price to Earnings Ratio (PE Ratio)?
NextCure, Inc. PE Ratio is now.
What was NextCure, Inc. earnings per share over the trailing 12 months (TTM)?
NextCure, Inc. EPS is -2.1 EUR over the trailing 12 months.
Which sector does the NextCure, Inc. company belong to?
The NextCure, Inc. sector is Healthcare.